Substituted anilinic piperidines as mch selective antagonists

Details Substituted anilinic piperidines as mch selective antagonists Substituted anilinic piperidines as mch selective antagonists

C - Chemistry, Metallurgy

07

D

C07D 413/12 (2006.01) A61K 31/445 (2006.01) A61K 31/4523 (2006.01) A61P 25/00 (2006.01) C07D 211/26 (2006.01) C07D 211/28 (2006.01) C07D 211/30 (2006.01) C07D 211/90 (2006.01) C07D 211/94 (2006.01) C07D 401/04 (2006.01) C07D 401/06 (2006.01) C07D 401/10 (2006.01) C07D 401/12 (2006.01) C07D 401/14 (2006.01) C07D 403/06 (2006.01) C07D 403/12 (2006.01) C07D 405/06 (2006.01) C07D 405/12 (2006.01) C07D 409/06 (2006.01) C07D 409/10 (2006.01) C07D 409/12 (2006.01) C07D 409/14 (2006.01) C07D 417/06 (2006.01) C07D 4

Patent

CA 2454613

This invention is directed to compounds which are selective antagonists for melanin concentrating hormone-1 (MCH1) receptors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of the compound of this invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier.

L'invention concerne des composés qui constituent des antagonistes sélectifs des récepteurs de l'hormone de concentration de la mélanine 1 (MCH1). L'invention concerne également une composition pharmaceutique contenant une quantité thérapeutiquement efficace du composé selon l'invention, et un excipient pharmaceutiquement acceptable. L'invention concerne en outre une composition pharmaceutique obtenue par combinaison d'une quantité thérapeutiquement efficace du composé selon l'invention et d'un excipient pharmaceutiquement acceptable. L'invention concerne également un procédé pour produire une composition pharmaceutique, ledit procédé consistant à combiner une quantité thérapeutiquement efficace du composé selon l'invention et un excipient pharmaceutiquement acceptable

Affiliated with

Also associated with

Rating

Substituted anilinic piperidines as mch selective antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted anilinic piperidines as mch selective antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted anilinic piperidines as mch selective antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1894633